View by Specialty

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

Neurology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 15, 2024
2 min read
Save

Prenatal air pollution exposure tied to increased risk for cerebral palsy

Prenatal air pollution exposure tied to increased risk for cerebral palsy

Prenatal exposure to ambient air pollution was associated with increased risk for children developing cerebral palsy, according to cohort study results published in JAMA Network Open.

SPONSORED CONTENT
July 15, 2024
5 min read
Save

Consider today’s options for covering the future cost of long-term care

Consider today’s options for covering the future cost of long-term care

As their parents age, many of our physician clients have asked us about long-term care insurance.

Trending

Drinking more coffee and tea lowers the risk for developng multiple cardiometabolic disorders.
September 17, 2024
3 min read
Save

Drinking moderate amounts of caffeine may cut risk for multiple cardiometabolic diseases

SPONSORED CONTENT
July 12, 2024
2 min read
Save

Taking soy protein before bed may improve sleep quality

Taking soy protein before bed may improve sleep quality

CHICAGO — A higher intake of protein, particularly soy, a half-hour before bed was tied to improved sleep quality in older adults, according to the results of a study presented at NUTRITION.

SPONSORED CONTENT
July 12, 2024
1 min read
Save

Vistagen announces new patents for investigational pherine nasal spray to treat migraine

Vistagen announces new patents for investigational pherine nasal spray to treat migraine

A clinical-stage neuroscience-focused biopharmaceutical company has received new international patents related to an investigational neuroactive pherine nasal spray to potentially treat individuals with migraine.

SPONSORED CONTENT
July 12, 2024
1 min read
Save

AI tools require precise language, content formulation to better assist medical education

AI tools require precise language, content formulation to better assist medical education

AI-generative tools such as ChatGPT may be a useful tool for medical education but require precise formulation of language and content to match and assist skills of human counterparts, according to new research from Brain and Spine.

SPONSORED CONTENT
July 11, 2024
2 min read
Save

CMS proposes cutting physician payments for fifth straight year

CMS proposes cutting physician payments for fifth straight year

CMS has released its proposed 2025 Medicare Physician Fee Schedule, or PFS, which includes a 2.93% cut in physician payments from the previous year, according to a press release.

SPONSORED CONTENT
July 11, 2024
2 min read
Save

No significant difference in clinical outcomes, recovery in college athletes with concussion

No significant difference in clinical outcomes, recovery in college athletes with concussion

No significant differences were found in clinical outcomes or recovery time in college athletes who returned to play following concussion compared with those immediately removed, according to research from Neurosurgical Focus.

SPONSORED CONTENT
July 11, 2024
1 min read
Save

Disease progression slowed by 80% at 24 months in phase 1/2 studies of HD gene therapy

Disease progression slowed by 80% at 24 months in phase 1/2 studies of HD gene therapy

Interim results of phase 1/2 clinical trials of an investigational gene therapy for Huntington’s disease showed that disease progression slowed by 80% at 24 months, according to the manufacturer.

SPONSORED CONTENT
July 10, 2024
2 min read
Save

Brain stimulation may have distinct near-maximal effective doses across mental disorders

Brain stimulation may have distinct near-maximal effective doses across mental disorders

Significant dose-response associations were found for transcranial magnetic stimulation and transcranial direct current stimulation across several mental disorders, including schizophrenia and depression, according to research.

SPONSORED CONTENT
July 10, 2024
1 min read
Save

Interim phase 1/2a study results positive for investigational Parkinson’s cell therapy

Interim phase 1/2a study results positive for investigational Parkinson’s cell therapy

A South Korean biomedical company has announced positive 1-year assessment data from a phase 1/2a clinical trial of a human embryonic stem cell-derived midbrain dopaminergic progenitor for Parkinson’s disease.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails